Gilead Sciences, Inc.
GILD · Healthcare · · USDFahodi Score HOLD Long-term (Investment)
64
/ 100
Technical
100
Trend & RS
92
Momentum
88
Fundamental
56
Macro
65
Liquidity
43
| Component | Score | Weight |
|---|---|---|
| Technical | 100.0 | 10% |
| Trend & RS | 92.3 | 10% |
| Momentum | 87.7 | 5% |
| Fundamental | 55.6 | 40% |
| Macro | 65.1 | 15% |
| Liquidity | 43.2 | 20% |
Trade Setup
| Entry | 167.93 |
| Stop Loss | 157.73 (6.1%) |
| Target 1 (1:1) | 178.13 (+6.1%) |
| Target 2 (2:1) | 188.33 (+12.2%) |
| ATR(14) | 5.10 (3.0%) |
| Risk per Share | 10.20 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 26.0 | -0.96 | |
| Momentum | 87.7 | +1.51 | |
| Quality | 8.4 | -1.67 | |
| Composite | 40.7 | ||
Quality Scores
Piotroski F-Score
1
/9 —
Weak
✗
✗
✗
✗
✗
✗
✗
✗
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
6.43
—
Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe
Valuation vs Peers Overvalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | N/A | 22.0 | Inline |
| P/B Ratio | 15.9 | 4.0 | Above |
| Dividend Yield | 2.0% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a premium to sector peers — verify growth justifies premium.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
42.22%
Full Kelly
21.11%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 64/100. Estimated win rate 59%, avg win 8.9%, avg loss 3.7%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
4
Bullish Signals
0
Bearish Signals
61.69
RSI(14)
5.4075
MACD
Relative Strength (RS) IMPROVING
80
/ 99
RS Rating
✓ O'Neil PASS (≥80)
| RS vs SPY | ↑ RISING (+30.9% vs SPY 3M) |
| RS vs Sector | OUTPERFORMING (Healthcare) |
| RS New High | Near 3-month high 1d since high |
| Sector Outperformance | +13.1% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
IMPROVING:
Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 61.69 | NEUTRAL |
| Macd | 5.4075 | BULLISH |
| Ma Cross | 152.88 / 139.77 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.12x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 176.58 |
| Bollinger Upper | 175.13 |
| SMA(200) | 139.77 |
| SMA(50) | 152.88 |
| SMA(20) | 160.14 |
| Current Price | 167.54 |
| Bollinger Lower | 145.16 |
| 52-Week Low | 116.88 |
| ATR(14) | 5.1 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
MARKUP
Confidence
100%
Acc: 0.0 |
Dist: 0.0 |
Markup: 2.0 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-11-02 | Normal | 1.29x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.96x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.4x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.65x | Normal bar — no special VSA pattern |
| 2026-11-06 | Normal | 0.12x | Normal bar — no special VSA pattern |
Ichimoku Cloud BULLISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 166.17 | Above Kijun |
| Kijun-sen (26) | 159.59 | Base line |
| Senkou A | 162.88 | Leading span A |
| Senkou B | 159.48 | Leading span B |
| Cloud | 159.48 – 162.88 | Bullish (Green) |
| Price vs Cloud | 167.93 | Above Cloud |
| Chikou Span | 144.74 | Bullish |
| Alignment Score | 4/4 | BULLISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BULLISH FADING
BB: 145.16 – 175.13 | KC: 152.47 – 167.81
Divergences (last 60 bars)
| Type | Indicator | Bars Ago | Strength |
|---|---|---|---|
| Regular Bearish | RSI | 17 |
Anchored VWAP
VWAP: 135.51
Anchor: 2025-11-10 (52w Low)
ABOVE AVWAP
+23.9%
Heikin-Ashi Trend
WEAKLY BEARISH
Full data via /api/advanced/GILD
Valuation
| Metric | Value |
|---|---|
| Market Cap | 207.81B |
| P/E (TTM) | N/A |
| Forward P/E | N/A |
| P/B | 15.94 |
| EPS | -3.13 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 6.8% |
| Profit Margin | -12.5% |
| ROE | -22.4% |
| Debt/Equity | 202.46 |
| Current Ratio | 1.38 |
| Dividend Yield | 2.0% |
| Payout Ratio | N/A |
| Beta | 0.37 |
Trading Data
167.54
Open
167.54
Day High
167.54
Day Low
887.6K
Volume (0.1x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)